Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
Hosted on MSN
New weekly injectable drug could transform the lives of people living with Parkinson’s disease
A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...
Northwestern Medicine scientists have discovered that targeting neuronal signaling controlling aberrant learning in the ...
DEAR DR. ROACH: I’m a 65-year-old and otherwise healthy male. After spending the past five years believing that my trembling hands were the result of essential tremor, a second DaT (dopamine ...
SAN DIEGO -- Both fixed and flexible doses of investigational tavapadon met their primary endpoint in phase III trials of early Parkinson's disease. In the TEMPO-1 (fixed dose) and TEMPO-2 (flexible ...
A man expressing sadness with his head in his hands. Image by Tellmeimok. (CC BY-SA 4.0) A man expressing sadness with his head in his hands. Image by Tellmeimok. (CC BY-SA 4.0) A drug used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback